Pet Ownership Fuels Growth In Veterinary Anti-Infectives Market: Strategic Insights Driving Veterinary Anti-infectives Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Veterinary Anti-infectives Market Size By 2025?
In the past, the size of the veterinary anti-infectives market has seen robust growth. It is projected to surge from $5.54 billion in 2024 to $6.02 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%. The growth in this historic period can be accredited to factors such as a rise in pet ownership, prevalence of infectious diseases, advancements in veterinary medicine, increasing awareness, and government initiatives.

How Big Is the Veterinary Anti-infectives Market Size Expected to Grow by 2029?
A substantial increase is predicted in the size of the veterinary anti-infectives market in the coming years. The market is projected to expand to $8.69 billion by 2029, with a compound annual growth rate (CAGR) of 9.6%. The growth expected in this period is due to several factors like the rising pet population, the emergence of zoonotic diseases, a globalized pet trade, and increased spending in veterinary healthcare. The forecast period is also set to witness some key trends such as technological improvements, a rise in the use of biologicals, the inclusion of telehealth in veterinary services, an emphasis on herbal and natural alternatives, the growth of e-commerce in veterinary pharmaceuticals, and strategic collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Key Market Drivers Powering Veterinary Anti-infectives Market Expansion and Growth?
The anticipated rise in pet ownership is likely to drive the growth of the veterinary anti-infectives market. This means owning a dog, cat, or any other domestic pet. As more and more young people are accepting pets as a part of their familial unit, driven by their fidelity, companionship and ability to alleviate solitude, pet adoption is on the rise. For example, data from Animal Medicines Australia, a non-governmental organization based in Australia, showed a substantial growth in pet ownership in 2022 with pet owner numbers escalating to 28,730.8, a rise from 39% in 2021, marking a 24% increase. This underscores the escalating trend of pet adoption and investement in their care. The increase in pet ownership exemplifies the growing fondness for pets in Australian households. As a result, the demand for the veterinary anti-infectives market is being fuelled by rising pet ownership.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Veterinary Anti-infectives Market?
Cutting-edge technology is an emerging trend in the veterinary anti-infectives market. Major market players leverage state-of-the-art technologies to maintain their market dominance. An example is Elanco Animal Health Incorporated, a US pharmaceutical firm that produces drugs and vaccines for pets and livestock. In February 2022, they introduced Increxxa, a newly approved medication for livestock respiratory disease. The primary active ingredient, tulathromycin, is administered via injection directly to the site of infection in the lungs for immediate response and extended half-life, thus offering cattle ample time to build a robust defense. Increxxa is engineered for veterinary application and its key ingredient, tulathromycin, helps mitigate the adverse effects of bovine respiratory disease.

What Are the Emerging Segments in the Veterinary Anti-infectives Market?
The veterinary anti-infectives market covered in this report is segmented -

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes
2) By Species Type: Livestock Animals, Companion Animals
3) By Mode Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:
1) By Antimicrobial Agents: Antibiotics, Antiseptics
2) By Antiviral Agents: Vaccines, Antiviral Medications
3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals
4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Who Are the Global Leaders in the Veterinary Anti-infectives Market?
Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Which are the Top Profitable Regional Markets for the Veterinary Anti-infectives Industry?
North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.